hepatitis C

Gilead gets FDA priority review of Hepatitis C combo drug
Marketwatch
Tue, 01/5/16 - 09:06 am
Gilead Sciences
FDA
priority review
hepatitis C
Sovaldi-velpatasir
Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up
Bidness, ETC
Wed, 12/30/15 - 07:07 pm
Gilead Sciences
AbbVie
hepatitis C
Sovaldi
Harvoni
Viekira Pak
The Price Keeps Falling For a Superstar Gilead Drug in India
Bloomberg
Tue, 12/29/15 - 09:33 am
India
Gilead Sciences
sofosbuvir
Sovaldi
hepatitis C
The Best Merck & Co. Inc. Headlines in 2015
Motley Fool
Thu, 12/24/15 - 10:18 am
Merck
Keytruda
Jimmy Carter
hepatitis C
grazoprevir/elbagavir
Merck’s Share Price Has Been Volatile on Impending Drug Approvals
Yahoo/Market Realist
Fri, 12/18/15 - 12:31 pm
Merck
elbasvir/grazoprevir
hepatitis C
Merck Will Soon See a Decision on Its New Hepatitis C Therapy
Yahoo/Market Realist
Thu, 12/17/15 - 01:52 pm
Merck
hepatitis C
grazoprevir/elbasvir
Gilead Sciences: Hep-C ‘Tracking Fine’ But What About 2016?
Barron's
Fri, 12/4/15 - 08:22 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
For Hepatitis C Drugs, U.S. Prices Are Cheaper Than In Europe
Forbes
Fri, 12/4/15 - 08:13 pm
hepatitis C
Europe
drug pricing
Gilead Sciences, Inc: Can the Senate Report Trigger Policy Changes?
Bidness, ETC
Thu, 12/3/15 - 09:35 am
Gilead Sciences
drug pricing
Senate
hepatitis C
Gilead considered $115K price for Sovaldi, Senate investigation says
Fierce Pharma
Wed, 12/2/15 - 05:52 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Senate
AbbVie Announces FDA Acceptance of New Drug Application for a Once-Daily Formulation of VIEKIRA PAK to Treat Genotype 1 Chronic Hepatitis C Virus Infection
Yahoo
Wed, 12/2/15 - 09:28 am
AbbVie
hepatitis C
Viekira Pak
Gilead put profit ahead of hepatitis C patients -U.S. Senate report
Yahoo/Reuters
Tue, 12/1/15 - 02:13 pm
Gilead Sciences
hepatitis C
Senate
4 Key FDA Decisions Expected By Year End
24/7 Wall St
Sun, 11/29/15 - 12:43 pm
FDA
Achillion
hepatitis C
Biocryst
OPuS-2
BCX4161
Tetraphase Pharmaceuticals
Lucitanib
Clovis Oncology
Bristol-Myers Lets Low-Income Countries Copy Hepatitis C Pills
Bloomberg
Mon, 11/23/15 - 10:14 am
Bristol-Myers Squibb
hepatitis C
Medicines Patent Pool
Daklinza
Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C
Motley Fool
Sat, 11/21/15 - 12:18 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Sciences: AbbVie, Merck Fail to ‘Mount a Major Threat’
Barron's
Wed, 11/18/15 - 03:53 pm
Gilead Sciences
AbbVie
Merck
hepatitis C
Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?
Bidness, ETC
Mon, 11/16/15 - 03:36 pm
Merck
Gilead Sciences
hepatitis C
MK-3682
grazoprevir/elbasvir
MK-8408
Study Shows Merck Hepatitis C Drug Cures Addicts
Bloomberg
Mon, 11/16/15 - 09:00 am
Merck
hepatitis C
IV drug use
Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Hepatitis C
Yahoo
Sun, 11/15/15 - 11:39 am
Merck
clinical trials
elbasvir/grazoprevir
hepatitis C
AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
Yahoo
Sat, 11/14/15 - 11:33 am
AbbVie
Viekira Pak
hepatitis C

Pages